Elranatamab-Bcmm (Anti-BCMA & CD3)
Product Specifications
CAS Number
2408850-14-4
Synonyms
ElrexfioTM, PF-06863135
SKU
C00876-1mg
Target
CD markers
Applications
Transmembrane Transporters
Additionnal Information
Elranatamab-bcmm is a bispecific T-cell engager (BiTE) monoclonal antibody that targets CD3 and B-cell maturation antigen (BCMA), promoting the recruitment and activation of T cells to effectively eliminate malignant myeloma cells. It is FDA-approved for the treatment of adults with relapsed or refractory multiple myeloma. MW: 145.44 KD.
Storage Conditions
-80°C (avoid freeze-thaw cycles)
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
035574-PE 200 µL
FBXW8, ID (FBXW8, FBW6, FBW8, FBX29, FBXO29, FBXW6, F-box/WD repeat-containing protein 8, F-box and WD-40 domain-containing protein 8, F-box only protein 29) (PE) discontinued
Ask
View Details 